SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10411075
Source:
http://linkedlifedata.com/resource/pubmed/id/10411075
Search
Subject
(
41
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0005684
,
umls-concept:C0022885
,
umls-concept:C0030705
,
umls-concept:C0035647
,
umls-concept:C0039593
,
umls-concept:C0332324
,
umls-concept:C0390930
pubmed:issue
2
pubmed:dateCreated
1999-8-17
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10411075-10037369
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0376374
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
,
http://linkedlifedata.com/resource/pubmed/chemical/nuclear matrix protein 22
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0022-5347
pubmed:author
pubmed-author:CasellaRR
,
pubmed-author:GasserT CTC
,
pubmed-author:LehmannKK
pubmed:issnType
Print
pubmed:volume
162
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
500-1
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10411075-Cost-Benefit Analysis
,
pubmed-meshheading:10411075-Humans
,
pubmed-meshheading:10411075-Nuclear Proteins
,
pubmed-meshheading:10411075-Pilot Projects
,
pubmed-meshheading:10411075-Risk Factors
,
pubmed-meshheading:10411075-Sensitivity and Specificity
,
pubmed-meshheading:10411075-Tumor Markers, Biological
,
pubmed-meshheading:10411075-Urinary Bladder Neoplasms
pubmed:year
1999
pubmed:articleTitle
Re: NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer.
pubmed:publicationType
Letter
,
Comment